Table 1.
Patient demographics and baseline characteristics (N = 21)
| Characteristic | N (%)a |
|---|---|
| Median age, years (range) | 65 (35–77) |
| Male/female | 13 (62)/8 (38) |
| Country | |
| Japan/Taiwan | 10 (48)/11 (52) |
| ECOG PS 0/1 | 11 (52)/10 (48) |
| Tumor type | |
| Stomach | 4 (19) |
| Colorectal | 3 (14) |
| Soft tissue sarcoma | 3 (14) |
| Otherb | 11 (52) |
| Median time since histological diagnosis, months (range) | 32.5 (15.4–178.0) |
| Prior anti-cancer therapiesc | |
| Chemotherapy | 20 (95) |
| ≥ 3 chemotherapy regimens | 14 (67) |
| Surgery | 17 (81) |
| Radiotherapy | 6 (29) |
| Other | 6 (29) |
ECOG PS Eastern Cooperative Oncology Group performance status
aUnless otherwise stated
bBiliary tree (n =2), bladder (n =2), esophageal (n =2), other (n =2), liver (n =1), melanoma (n =1), prostate (n =1)
cPatients could have received more than one type of prior therapy